Characteristic Study on Chinese Patients With Multiple Sclerosis
NCT00818103 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 600
Last updated 2009-09-29
Summary
Compared with MS in white populations, in people of China descent multiple sclerosis (MS)is characterized by lower prevalence, more frequent and severe involvement of the visual system at onset and during the entire clinical course, more common occurrence of optic and spinal involvement, relatively rapid progression and less common occurrence of a progressive course. Data are not available for mainland China that are focused on characteristic studies of MS. In this study, the investigators sought to explore the characteristics of MS among Chinese in China, by conducting a study on genetics, pathogenesis, pathology, neuroimaging characteristics, and so on. Based on these data, the investigators try to explore the difference in neuromyelitis optical (NMO) and MS and provide clinical data for treatment guidelines for NNO and MS.
Conditions
Interventions
- DRUG
-
Atorvastatin 40mg p.o. qn for 2 years
- DRUG
-
β-interferon
β-interferon 50ug i.m. qod for 2 years
- DRUG
-
EPO
EPO 10000U i.h. bid for 5 days
Sponsors & Collaborators
-
Third Affiliated Hospital, Sun Yat-Sen University
collaborator OTHER -
Sun Yat-sen University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-01-31
- Primary Completion
- 2015-01-31
- Completion
- 2016-01-31
Countries
- China
Study Locations
More Related Trials
-
Self-compassion for People with Multiple Sclerosis: an Exploratory Feasibility Study
NCT06337903 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
The Use of Technology to Improve MS Clinical Trials and Patient Care
NCT02454907 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Mechanisms of Disease Severity in Multiple Sclerosis: an Integrative Multimodal Study
NCT03369106 ·Status: ACTIVE_NOT_RECRUITING
-
Serum Neurofilament Light in Multiple Sclerosis
NCT06282081 ·Status: ACTIVE_NOT_RECRUITING
-
To Study the Pathophysiological Features of Multiple Sclerosis
NCT04242056 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Incidence, and Survival Medical Expenditure of Patients With Multiple Sclerosis
NCT04022564 ·Status: UNKNOWN
-
A Study of A4I Antagonist in Patients With Relapsing Multiple Sclerosis.
NCT00104143 ·Status: WITHDRAWN ·Phase: PHASE2
-
Study of Efficacy and Safety of Ofatumumab in Relapsing Multiple Sclerosis (RMS) Patients in China
NCT05199571 ·Status: COMPLETED ·Phase: PHASE4
-
The Regulatory Role of miRNA 27 Follistatin Like Protein-1 Gene in Multiple Scelerosis
NCT06290453 ·Status: NOT_YET_RECRUITING
-
Relationship Between the Nutritional Habits and Relapsing and Disability Rates in Patient With Multiple Sclerosis.
NCT04110171 ·Status: UNKNOWN
-
EARLY IFNb-1a and Atorvastatin Combination Therapy of Isolated Clinical Syndrome Suggestive of Multiple Sclerosis
NCT00137176 ·Status: COMPLETED ·Phase: NA
-
A Study to Assess the Effects of MK0812 on Disease Activity in Patients With Relapsing-Remitting Multiple Sclerosis as Measured by Magnetic Resonance Imaging (MRI)(0812-003)(COMPLETED)
NCT00239655 ·Status: TERMINATED ·Phase: PHASE2
-
Atorvastatin (Lipitor) Therapy in Patients With Clinically Isolated Syndrome (CIS) at Risk for Multiple Sclerosis
NCT00094172 ·Status: COMPLETED ·Phase: PHASE2
-
Advanced MRI Sequences in Multiple Sclerosis and Its Mimics
NCT03608605 ·Status: UNKNOWN
-
Characterization of Early Patients Initiating Ofatumumab for Treatment of Multiple Sclerosis.
NCT05576779 ·Status: COMPLETED
-
Autologous Mesenchymal Stem Cell (MSC) Transplantation in MS
NCT00813969 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of C105 on Cognitive Dysfunction in Persons With Multiple Sclerosis
NCT00529581 ·Status: COMPLETED ·Phase: PHASE2
-
Application of Multiparametric Structural and Functional MRI in Unraveling the Substrates of Cognitive Impairment and Disability in Multiple Sclerosis
NCT06653283 ·Status: NOT_YET_RECRUITING
-
Masitinib in Primary Progressive Multiple Sclerosis or Relapse-free Secondary Progressive Multiple Sclerosis
NCT01450488 ·Status: COMPLETED ·Phase: PHASE2
-
Natural Antioxidants in the Treatment of Multiple Sclerosis
NCT00010842 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Evaluation of Sloan-Charts for Assessment of Disease Progress in Multiple Sclerosis
NCT01272596 ·Status: COMPLETED
-
Decision Making in Multiple Sclerosis Care Under Uncertainty
NCT04035720 ·Status: UNKNOWN ·Phase: NA
-
Out of Pocket Cost Communication in Multiple Sclerosis Patients
NCT04257071 ·Status: COMPLETED ·Phase: NA
-
A Study of Multiple Sclerosis Routine Clinical Practice: Impact on Adherence and Clinical Outcomes of Ofatumumab Treated Patients
NCT06897657 ·Status: COMPLETED
-
Progression of Cognitive and Physical Symptoms in Multiple Sclerosis
NCT00922831 ·Status: WITHDRAWN